Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06066970 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery

Study acronym: RORSCHACH
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint revisedv2 Show 4 more changesShow less
    • Study sites: 1 to 5
    • Primary completion date: Mar 2025 to Sep 2025
    • Study completion date: Mar 2025 to Dec 31, 2025
    • Eligibility criteria revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to clarify whether the perioperative release of the cardiac biomarkers troponin I, troponin T and CK-MB consistently correlate with visualizable myocardial damage, and to what extent these biomarkers are comparable by means of their kinetics and dynamics. Due to the uncertainty regarding the validity of cardiac biomarkers in the diagnosis of myocardial infarction, the answer to these questions could have a considerable influence on internationally valid guidelines and definitions. International studies, especially in the field of coronary surgery and coronary artery disease treatment refer to these definitions, in particular, the adequate treatment of affected patients is directly dependent on them.
Trial Details
NCT Number NCT06066970
Lead Sponsor Jena University Hospital
Conditions
(from sponsor)		 Cardiac Valve Disease
Related terms Heart Valve Diseases
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov